-
August 19, 2024The efficacy and safety of ISIS 449884 injection as monotherapy in patients with type 2 diabetes: A randomized phase II study
DOI: 10.1111/dom.15862
-
July 15, 2024ISIS 449884 Injection Add‑On to Metformin in Patients with Type 2 Diabetes: A Randomized, Double‑Blind, Placebo‑Controlled, Phase II Clinical Study
DOI: 10.1007/s13300-024-01617-3
-
May 24, 2024Analysis of the pharmacokinetics and efficacy of RBD1016 – A GalNAc-siRNA targeting Hepatitis B Virus X gene using semi-mechanistic PK/PD model
DOI: 10.1016/j.heliyon.2024.e31924
-
November 15, 2023Metabolite identification and quantitation of RBD1016 siRNA: a direct comparison of hybridization-based LC-FD and LC-HRAM assays
DOI: 10.4155/bio-2023-0161
-
November 2, 2023Regional differences and coronary microvascular dysfunction in heart failure with preserved ejection fraction
DOI: 10.1002/ehf2.14569
-
May 4, 2023Feasibility of high-dose tadalafil and effects on insulin resistance in well-controlled patients with type 2 diabetes (MAKROTAD): a single-centre, double-blind, randomised, placebo-controlled, cross-over phase 2 trial
DOI: 10.1016/j.eclinm.2023.101985